Elizabeth M Swisher Selected Research

Messenger RNA (mRNA)

1/2016	The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.
3/2013	53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth M Swisher Research Topics

Disease

70	Neoplasms (Cancer) 05/2024 - 03/2002
66	Carcinoma (Carcinomatosis) 03/2024 - 03/2007
56	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 04/2002
16	Breast Neoplasms (Breast Cancer) 08/2023 - 05/2002
7	Ovarian Epithelial Carcinoma 09/2023 - 09/2005
7	Triple Negative Breast Neoplasms 01/2023 - 11/2013
6	Fatigue 01/2022 - 07/2017
5	Anemia 05/2023 - 11/2017
5	Disease Progression 01/2023 - 01/2017
4	Genomic Instability 01/2024 - 01/2018
4	Thrombocytopenia (Thrombopenia) 01/2023 - 10/2017
4	Nausea 01/2020 - 11/2017
3	Neutropenia 01/2023 - 01/2018
3	Carcinogenesis 01/2022 - 05/2002
3	Asthenia 01/2021 - 11/2017
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2013 - 06/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 02/2008
2	Vomiting 01/2020 - 11/2017
2	Neoplasm Metastasis (Metastasis) 10/2017 - 01/2007
2	Endometrial Hyperplasia 07/2012 - 07/2008
2	Ascites 05/2012 - 08/2009
1	Adenocarcinoma 12/2023
1	Hypoxia (Hypoxemia) 12/2023
1	Stomach Neoplasms (Stomach Cancer) 12/2023
1	Leukemia 11/2023
1	Sertoli-Leydig Cell Tumor 08/2023
1	Pain (Aches) 05/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Heart Failure 01/2023
1	Bloom Syndrome 01/2023
1	Sepsis (Septicemia) 01/2023
1	Leukopenia 01/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Peritoneal Neoplasms 10/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021

Drug/Important Bio-Agent (IBA)

45	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 04/2011
39	PlatinumIBA 05/2024 - 04/2008
22	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 05/2002
21	rucaparibIBA 03/2023 - 01/2017
18	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2005
17	Proteins (Proteins, Gene)FDA Link 09/2023 - 12/2007
12	veliparibIBA 01/2023 - 06/2015
11	olaparibIBA 05/2024 - 07/2017
11	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023 - 04/2015
10	Carboplatin (JM8)FDA LinkGeneric 09/2023 - 04/2011
8	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 06/2006
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 11/2016
4	cediranib (AZD2171)IBA 05/2024 - 07/2017
4	Poly Adenosine Diphosphate RiboseIBA 01/2023 - 08/2019
4	Bevacizumab (Avastin)FDA Link 12/2022 - 01/2018
4	niraparibIBA 09/2021 - 11/2016
4	BRCA1 ProteinIBA 12/2019 - 04/2008
3	prexasertibIBA 03/2024 - 01/2018
3	AntigensIBA 01/2023 - 10/2017
3	AlpelisibIBA 01/2022 - 01/2019
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2007
3	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2019
3	Immune Checkpoint InhibitorsIBA 01/2020 - 11/2017
3	Circulating Tumor DNAIBA 01/2019 - 09/2005
3	MicroRNAs (MicroRNA)IBA 01/2018 - 07/2010
3	Protein Isoforms (Isoforms)IBA 01/2016 - 09/2010
3	Platinum Compounds (Compounds, Platinum)IBA 01/2016 - 02/2008
2	Indicators and Reagents (Reagents)IBA 03/2023 - 01/2023
2	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2020
2	CreatinineIBA 01/2021 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2017
2	Codon (Codons)IBA 01/2020 - 03/2007
2	durvalumabIBA 01/2020 - 07/2017
2	pembrolizumabIBA 01/2020 - 08/2019
2	Messenger RNA (mRNA)IBA 01/2016 - 03/2013
2	Tumor Suppressor p53-Binding Protein 1IBA 10/2013 - 03/2013
2	MutL Protein Homolog 1IBA 01/2013 - 07/2009
2	Progestins (Progestagens)IBA 07/2012 - 07/2008
2	Epithelial Cell Adhesion MoleculeIBA 07/2012 - 05/2012
2	BRCA2 ProteinIBA 08/2009 - 07/2009
2	Estrogens (Estrogen)FDA Link 01/2007 - 05/2002
1	TabletsIBA 05/2024
1	RamucirumabIBA 12/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 05/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2023
1	AfatinibIBA 05/2023
1	ibrutinibIBA 05/2023
1	Checkpoint Kinase 1IBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	RecQ HelicasesIBA 01/2023
1	CyclinsIBA 01/2023
1	eribulin FDA Link 01/2023
1	IS 35IBA 01/2023
1	MutagensIBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	TFXIBA 01/2022

Therapy/Procedure

37	Therapeutics 01/2024 - 03/2002
33	Drug Therapy (Chemotherapy) 08/2023 - 03/2007
7	Salpingo-oophorectomy 08/2023 - 06/2006
4	Ovariectomy (Oophorectomy) 01/2023 - 04/2002
2	Precision Medicine 05/2023 - 10/2021
2	Salpingectomy 01/2023 - 01/2020
1	Castration 01/2023